HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wei Yin Selected Research

platinum 109

4/2022PT109, a novel multi-kinase inhibitor suppresses glioblastoma multiforme through cell reprogramming: Involvement of PTBP1/PKM1/2 pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wei Yin Research Topics

Disease

73Neoplasms (Cancer)
07/2022 - 08/2007
18Inflammation (Inflammations)
01/2022 - 01/2008
14Ischemia
12/2021 - 02/2002
13Infections
01/2022 - 10/2015
13Hypoxia (Hypoxemia)
12/2021 - 09/2002
9Neoplasm Metastasis (Metastasis)
01/2022 - 04/2013
9Brain Ischemia (Cerebral Ischemia)
12/2019 - 02/2002
8Glioma (Gliomas)
05/2022 - 08/2007
7Brain Injuries (Brain Injury)
01/2021 - 09/2002
7Infarction (Infarctions)
06/2015 - 02/2002
6Alzheimer Disease (Alzheimer's Disease)
01/2022 - 04/2014
6Lung Neoplasms (Lung Cancer)
07/2020 - 01/2017
6Hepatocellular Carcinoma (Hepatoma)
01/2020 - 01/2016
6Stroke (Strokes)
12/2019 - 04/2006
5Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)
09/2021 - 11/2011
5Hypertension (High Blood Pressure)
08/2021 - 12/2004
5Stomach Neoplasms (Stomach Cancer)
02/2021 - 01/2013
5Wounds and Injuries (Trauma)
01/2020 - 03/2011
5Breast Neoplasms (Breast Cancer)
02/2018 - 01/2000
4COVID-19
02/2022 - 10/2020
4Ischemic Stroke
01/2022 - 10/2013
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2018
4Pneumonia (Pneumonitis)
01/2022 - 03/2019
4Fibrosis (Cirrhosis)
12/2021 - 11/2018
4Thrombosis (Thrombus)
10/2021 - 01/2008
4Virus Diseases (Viral Diseases)
01/2021 - 07/2014
4Neuroinflammatory Diseases
01/2019 - 01/2017
4Melanoma (Melanoma, Malignant)
01/2019 - 01/2016
4Purpura
09/2012 - 08/2010
3Glioblastoma (Glioblastoma Multiforme)
04/2022 - 01/2018
3Dental Caries (Decay, Dental)
01/2022 - 06/2010
3Disease Progression
01/2022 - 07/2014
3Body Weight (Weight, Body)
10/2020 - 01/2016
3Glaucoma
05/2019 - 07/2015
3Tongue Neoplasms (Tongue Neoplasm)
01/2019 - 01/2016
3Cardiovascular Diseases (Cardiovascular Disease)
02/2017 - 05/2009
3Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2016 - 04/2006
2Pathologic Constriction (Stenosis)
05/2022 - 01/2009
2Critical Illness (Critically Ill)
01/2022 - 05/2021
2Hemorrhage
01/2022 - 02/2016

Drug/Important Bio-Agent (IBA)

28Proteins (Proteins, Gene)FDA Link
02/2022 - 02/2002
18Pharmaceutical PreparationsIBA
01/2022 - 01/2010
10Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2017
10CytokinesIBA
01/2021 - 04/2006
9MicroRNAs (MicroRNA)IBA
07/2022 - 12/2016
9Neuroprotective AgentsIBA
01/2021 - 03/2015
8Biological ProductsIBA
01/2022 - 06/2017
7Reactive Oxygen Species (Oxygen Radicals)IBA
10/2020 - 03/2016
6Oxygen (Dioxygen)IBA
12/2021 - 02/2002
6ProdrugsIBA
10/2020 - 03/2016
5Complement System Proteins (Complement)IBA
10/2021 - 01/2008
5CholesterolIBA
08/2021 - 12/2004
5Antiviral Agents (Antivirals)IBA
10/2020 - 10/2014
5Glutathione (Reduced Glutathione)IBA
10/2020 - 09/2017
5Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
08/2020 - 03/2016
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 10/2008
5SteroidsIBA
01/2020 - 10/2013
5Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
01/2019 - 08/2007
5MicellesIBA
11/2018 - 03/2016
4Indicators and Reagents (Reagents)IBA
02/2022 - 01/2015
4Glutamic Acid (Glutamate)FDA Link
01/2022 - 08/2014
4Glucose (Dextrose)FDA LinkGeneric
12/2021 - 10/2003
4Messenger RNA (mRNA)IBA
06/2021 - 02/2002
4Interleukin-6 (Interleukin 6)IBA
06/2021 - 01/2016
4Cisplatin (Platino)FDA LinkGeneric
01/2021 - 12/2016
4VaccinesIBA
01/2021 - 06/2019
4Retinaldehyde (Retinal)IBA
05/2019 - 10/2008
4EnzymesIBA
01/2019 - 07/2014
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2018 - 09/2008
4SmokeIBA
02/2017 - 01/2008
3Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
05/2022 - 01/2009
3CateninsIBA
05/2022 - 08/2017
3Monoclonal AntibodiesIBA
02/2022 - 05/2014
3ErbB Receptors (EGF Receptor)IBA
01/2022 - 01/2020
3CreatinineIBA
12/2021 - 08/2019
3DNA (Deoxyribonucleic Acid)IBA
07/2020 - 01/2017
3Adenosine Monophosphate (AMP)IBA
01/2019 - 01/2014
3PlatinumIBA
10/2018 - 01/2017
3ElementsIBA
01/2018 - 08/2007
3AntioxidantsIBA
11/2017 - 06/2016
3Epithelial Cell Adhesion MoleculeIBA
01/2017 - 04/2013
3Carrier Proteins (Binding Protein)IBA
02/2016 - 08/2007
3Intravenous Immunoglobulins (IVIG)FDA Link
02/2016 - 12/2013
3Cholera ToxinIBA
05/2014 - 08/2007
2Thromboplastin (Tissue Factor)IBA
05/2022 - 01/2009
2ThrombinFDA Link
05/2022 - 10/2021
2Phosphotransferases (Kinase)IBA
04/2022 - 10/2008
2Therapeutic UsesIBA
04/2022 - 01/2018
2Insulin (Novolin)FDA Link
02/2022 - 01/2021
2AZD3759IBA
01/2022 - 12/2021

Therapy/Procedure

32Therapeutics
01/2022 - 06/2002
6Ligation
05/2022 - 09/2002
5Drug Therapy (Chemotherapy)
10/2019 - 03/2016
4Intravenous Injections
10/2020 - 05/2017
4Radiotherapy
08/2020 - 05/2017
3Immunotherapy
01/2022 - 01/2021
3Punctures
03/2021 - 09/2008
3Transplantation
10/2019 - 01/2016
3Oncolytic Virotherapy
01/2018 - 02/2016
2Aftercare (After-Treatment)
01/2022 - 02/2018